166 related articles for article (PubMed ID: 3810564)
1. Anticoagulant and antithrombotic properties of a gamma-carboxyglutamic acid-rich peptide derived from the light chain of blood coagulation factor X.
Nawroth PP; Kisiel W; Stern DM
Thromb Res; 1986 Dec; 44(5):625-37. PubMed ID: 3810564
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prothrombin activation by factor X and factor IX Gla-peptides.
Wildgoose P; Kisiel W
Biochem Biophys Res Commun; 1988 May; 152(3):1207-12. PubMed ID: 3377773
[TBL] [Abstract][Full Text] [Related]
3. The gamma-carboxyglutamic acid and epidermal growth factor-like domains of factor X. Effect of isolated domains on prothrombin activation and endothelial cell binding of factor X.
Persson E; Valcarce C; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2453-8. PubMed ID: 1989997
[TBL] [Abstract][Full Text] [Related]
4. Binding properties of the coagulation factor IX/factor X-binding protein isolated from the venom of Trimeresurus flavoviridis.
Atoda H; Yoshida N; Ishikawa M; Morita T
Eur J Biochem; 1994 Sep; 224(2):703-8. PubMed ID: 7925387
[TBL] [Abstract][Full Text] [Related]
5. Coagulation factor IX residues G4-Q11 mediate its interaction with a shared factor IX/IXa binding site on activated platelets but not the assembly of the functional factor X activating complex.
Ahmad SS; Wong MY; Rawala R; Jameson BA; Walsh PN
Biochemistry; 1998 Feb; 37(6):1671-9. PubMed ID: 9484238
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor X-binding protein from Deinagkistrodon acutus venom is a Gla domain-binding protein.
Atoda H; Ishikawa M; Mizuno H; Morita T
Biochemistry; 1998 Dec; 37(50):17361-70. PubMed ID: 9860851
[TBL] [Abstract][Full Text] [Related]
7. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
[TBL] [Abstract][Full Text] [Related]
8. Effects of gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IX on factor X activation. Studies using proteolytic fragments of bovine factor IX.
Astermark J; Hogg PJ; Björk I; Stenflo J
J Biol Chem; 1992 Feb; 267(5):3249-56. PubMed ID: 1737781
[TBL] [Abstract][Full Text] [Related]
9. The gamma-carboxyglutamic acid and epidermal growth factor-like modules of factor IXa beta. Effects on the serine protease module and factor X activation.
Astermark J; Hogg PJ; Stenflo J
J Biol Chem; 1994 Feb; 269(5):3682-9. PubMed ID: 8106413
[TBL] [Abstract][Full Text] [Related]
10. Membrane binding properties of the factor IX gamma-carboxyglutamic acid-rich domain prepared by chemical synthesis.
Jacobs M; Freedman SJ; Furie BC; Furie B
J Biol Chem; 1994 Oct; 269(41):25494-501. PubMed ID: 7929250
[TBL] [Abstract][Full Text] [Related]
11. Interaction of calcium with native and decarboxylated human factor X. Effect of proteolysis in the autolysis loop on catalytic efficiency and factor Va binding.
Sabharwal AK; Padmanabhan K; Tulinsky A; Mathur A; Gorka J; Bajaj SP
J Biol Chem; 1997 Aug; 272(35):22037-45. PubMed ID: 9268343
[TBL] [Abstract][Full Text] [Related]
12. High-affinity, specific factor IXa binding to platelets is mediated in part by residues 3-11.
Ahmad SS; Rawala-Sheikh R; Cheung WF; Jameson BA; Stafford DW; Walsh PN
Biochemistry; 1994 Oct; 33(40):12048-55. PubMed ID: 7918424
[TBL] [Abstract][Full Text] [Related]
13. Protein structural requirements for Ca2+ binding to the light chain of factor X. Studies using isolated intact fragments containing the gamma-carboxyglutamic acid region and/or the epidermal growth factor-like domains.
Persson E; Björk I; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2444-52. PubMed ID: 1989996
[TBL] [Abstract][Full Text] [Related]
14. Comparison of coagulation factor Xa and des-(1-44)factor Xa in the assembly of prothrombinase.
Skogen WF; Esmon CT; Cox AC
J Biol Chem; 1984 Feb; 259(4):2306-10. PubMed ID: 6698966
[TBL] [Abstract][Full Text] [Related]
15. Comparison of lipid binding and kinetic properties of normal, variant, and gamma-carboxyglutamic acid modified human factor IX and factor IXa.
Jones ME; Griffith MJ; Monroe DM; Roberts HR; Lentz BR
Biochemistry; 1985 Dec; 24(27):8064-9. PubMed ID: 3879187
[TBL] [Abstract][Full Text] [Related]
16. A novel blood coagulation factor IX/factor X-binding protein with anticoagulant activity from the venom of Trimeresurus flavoviridis (Habu snake): isolation and characterization.
Atoda H; Morita T
J Biochem; 1989 Nov; 106(5):808-13. PubMed ID: 2613688
[TBL] [Abstract][Full Text] [Related]
17. The epidermal growth factor-like domains of factor IX. Effect on blood clotting and endothelial cell binding of a fragment containing the epidermal growth factor-like domains linked to the gamma-carboxyglutamic acid region.
Astermark J; Stenflo J
J Biol Chem; 1991 Feb; 266(4):2438-43. PubMed ID: 1989995
[TBL] [Abstract][Full Text] [Related]
18. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
19. Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed.
Morita T; Jackson CM
J Biol Chem; 1986 Mar; 261(9):4015-23. PubMed ID: 3512564
[TBL] [Abstract][Full Text] [Related]
20. Snake-venom-derived Factor IX-binding protein specifically blocks the gamma-carboxyglutamic acid-rich-domain-mediated membrane binding of human Factors IX and X.
Gopinath SC; Shikamoto Y; Mizuno H; Kumar PK
Biochem J; 2007 Jul; 405(2):351-7. PubMed ID: 17407444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
